Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3.48M
-
Shares change
-
+930K
-
Total reported value, excl. options
-
$20.7M
-
Value change
-
+$5.85M
-
Put/Call ratio
-
2.74
-
Number of buys
-
16
-
Number of sells
-
-14
-
Price
-
$5.94
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2023
43 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2023.
XBiotech Inc. - Common Shares, no par value (XBIT) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.48M shares
of 30.8M outstanding shares and own 11.31% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (960K shares), VANGUARD GROUP INC (872K shares), BlackRock Inc. (290K shares), CREDIT SUISSE AG/ (245K shares), GEODE CAPITAL MANAGEMENT, LLC (173K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (127K shares), MORGAN STANLEY (83.9K shares), DIMENSIONAL FUND ADVISORS LP (74.3K shares), Connor, Clark & Lunn Investment Management Ltd. (64.3K shares), and STATE STREET CORP (56.5K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.